Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Dadvar Medical AB
AB
Active
Org 5591712806
Vimpelgatan 41
General medical practice activities · NACE 8621
Est. 2018
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 317K
+94% vs 2024
EBITDA margin
32.5%
+156% vs 2024
Equity ratio
75.8%
Financial strength
Net profit 2025
SEK 83K
+176% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 317K
+94%
EBITDA
SEK 103K
+156%
Net profit
SEK 83K
+176%
Total assets
SEK 215K
+92%
Equity
SEK 163K
+103%
Employees
0
—
Company information
Legal name
Dadvar Medical AB
Org number
5591712806
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
12 september 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Medicinsk konsultverksamhet.
Contact
Address
Vimpelgatan 41
Email
bamshadster@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Ljungby
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
248
214
282
163
317
Staff expenses
—
−44
−105
−3
—
EBITDA
146
49
82
40
103
Depreciation & amort.
−0
—
—
—
−0
EBIT
146
49
82
40
103
Net financials
−1
−0
0
−0
—
Profit before tax
145
49
82
40
103
Tax
−34
−12
−18
−10
−20
Net profit
111
37
64
30
83
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
272
243
168
112
215
Equity
234
121
114
80
163
Long-term debt
21
74
−5
−1
20
Short-term debt
60
48
59
33
72
Total debt
81
122
54
32
92
Financial ratios
5-year trend
EBITDA margin
32.5%
This company
15.8%
Market median
+106% vs market
2021
2025
Equity ratio
75.8%
This company
38.2%
Market median
+98% vs market
2021
2025
Return on equity
50.9%
This company
18.4%
Market median
+177% vs market
2021
2025
Net profit margin
26.2%
This company
8.1%
Market median
+223% vs market
2021
2025
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
2021
2025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
ED
Elham Dadvar
Board of Directors
2022
AB
Amir Bamshad Behbahani
Chairman
2022
AB
Ahmad Behbahani
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Dadvar Medical AB also hold positions in
0
other companies.
Person
Role here
Other companies
Elham Dadvar
Board of Directors
0 companies
Amir Bamshad Behbahani
Chairman
0 companies
Ahmad Behbahani
Deputy Board Member
0 companies